- Home
- VIR vs DEA Comparison
VIR vs DEA Comparison
Compare VIR & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- DEA
- Stock Information
- Founded
- VIR 2016
- DEA 2011
- Country
- VIR United States
- DEA United States
- Employees
- VIR N/A
- DEA N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- DEA Real Estate Investment Trusts
- Sector
- VIR Health Care
- DEA Real Estate
- Exchange
- VIR Nasdaq
- DEA Nasdaq
- Market Cap
- VIR 844.9M
- DEA 844.3M
- IPO Year
- VIR 2019
- DEA 2015
- Fundamental
- Price
- VIR $5.30
- DEA $20.26
- Analyst Decision
- VIR Strong Buy
- DEA Hold
- Analyst Count
- VIR 7
- DEA 4
- Target Price
- VIR $33.57
- DEA $29.06
- AVG Volume (30 Days)
- VIR 1.0M
- DEA 878.1K
- Earning Date
- VIR 05-07-2025
- DEA 04-29-2025
- Dividend Yield
- VIR N/A
- DEA 4.80%
- EPS Growth
- VIR N/A
- DEA N/A
- EPS
- VIR N/A
- DEA 0.41
- Revenue
- VIR $20,861,000.00
- DEA $314,385,000.00
- Revenue This Year
- VIR N/A
- DEA $6.87
- Revenue Next Year
- VIR $10.65
- DEA $7.97
- P/E Ratio
- VIR N/A
- DEA $49.14
- Revenue Growth
- VIR N/A
- DEA 6.82
- 52 Week Low
- VIR $4.95
- DEA $19.33
- 52 Week High
- VIR $14.45
- DEA $36.31
- Technical
- Relative Strength Index (RSI)
- VIR 34.32
- DEA 37.16
- Support Level
- VIR $5.04
- DEA $19.82
- Resistance Level
- VIR $6.29
- DEA $21.33
- Average True Range (ATR)
- VIR 0.29
- DEA 0.67
- MACD
- VIR -0.00
- DEA 0.20
- Stochastic Oscillator
- VIR 20.54
- DEA 46.47
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.